19 Utility of blood tests after completion of maintenance durvalumab after radical chemo-radiotherapy in patients with Non Small Cell Lung Cancer stage III

PACIFIC study of adjuvant durvalumab after radical chemoradiotherapy follow-up with 3 monthly blood checks for a year after completion of immunotherapy. We aimed to assess adherence and the added value of this post-treatment routine surveillance in our practice.

Source: Lung Cancer - April 1, 2024 Category: Cancer & Oncology Authors: Domingo Vicente Cano Gil, Abu Taher, Charlotte Milner-Watts, Alexius John, Faisal Rehman, David McMahon, Michael Davidson, Anna Minchom, Yousaf Nadia, Nadza Tokaca, Sanjay Popat, Jaishree Bhosle, Mary O'Brien Tags: Clinical Networks and Pathways Source Type: research